Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Cellular and Molecular Gastroenterology and Hepatology
|
January 22, 2020
Micronutrient Deficiency in Inflammatory Bowel Diseases: Cause or Effect?
Dulari Jayawardena, Pradeep K Dudeja
Methods in Molecular Biology (Clifton, N.J.)
|
June 1, 2019
Phospholipid Micelles for Peptide Drug Delivery
Karina Esparza, Dulari Jayawardena, Hayat Onyuksel
Nanomaterials (Basel, Switzerland)
|
March 28, 2017
Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis
Fatima Khaja, Dulari Jayawardena, Antonina Kuzmis, et al.
F1000Research
|
December 12, 2019
Recent advances in understanding and managing malabsorption: focus on microvillus inclusion disease
Dulari Jayawardena, Waddah A Alrefai, Pradeep K Dudeja, et al.
Molecular Pharmaceutics
|
October 10, 2017
Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease
Dulari Jayawardena, Arivarasu N Anbazhagan, Grace Guzman, et al.
Digestive Diseases and Sciences
|
November 20, 2019
Ion Transport Basis of Diarrhea in a Mouse Model of Adoptive T Cell Transfer Colitis
Dulari Jayawardena, Sangeeta Tyagi, Ali Nazmi, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 8, 2017
Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine
Dulari Jayawardena, Grace Guzman, Ravinder K Gill, et al.
Nanomedicine (London, England)
|
September 25, 2020
Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule
Dulari Jayawardena, Arivarasu N Anbazhagan, Shubha Priyamvada, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 30, 2024
SLC26A3 (DRA, the Congenital Chloride Diarrhea Gene): A Novel Therapeutic Target for Diarrheal Diseases
Anoop Kumar, Dulari Jayawardena, Shubha Priyamvada, et al.
American Journal of Physiology. Cell Physiology
|
September 5, 2019
Decreased SLC26A3 expression and function in intestinal epithelial cells in response to <i>Cryptosporidium parvum</i> infection
Anoop Kumar, Dulari Jayawardena, Arivarasu N Anbazhagan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Cellular and Molecular Gastroenterology and Hepatology
|
January 22, 2020
Micronutrient Deficiency in Inflammatory Bowel Diseases: Cause or Effect?
Dulari Jayawardena, Pradeep K Dudeja
Methods in Molecular Biology (Clifton, N.J.)
|
June 1, 2019
Phospholipid Micelles for Peptide Drug Delivery
Karina Esparza, Dulari Jayawardena, Hayat Onyuksel
Nanomaterials (Basel, Switzerland)
|
March 28, 2017
Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis
Fatima Khaja, Dulari Jayawardena, Antonina Kuzmis, et al.
F1000Research
|
December 12, 2019
Recent advances in understanding and managing malabsorption: focus on microvillus inclusion disease
Dulari Jayawardena, Waddah A Alrefai, Pradeep K Dudeja, et al.
Molecular Pharmaceutics
|
October 10, 2017
Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease
Dulari Jayawardena, Arivarasu N Anbazhagan, Grace Guzman, et al.
Digestive Diseases and Sciences
|
November 20, 2019
Ion Transport Basis of Diarrhea in a Mouse Model of Adoptive T Cell Transfer Colitis
Dulari Jayawardena, Sangeeta Tyagi, Ali Nazmi, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
April 8, 2017
Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine
Dulari Jayawardena, Grace Guzman, Ravinder K Gill, et al.
Nanomedicine (London, England)
|
September 25, 2020
Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule
Dulari Jayawardena, Arivarasu N Anbazhagan, Shubha Priyamvada, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 30, 2024
SLC26A3 (DRA, the Congenital Chloride Diarrhea Gene): A Novel Therapeutic Target for Diarrheal Diseases
Anoop Kumar, Dulari Jayawardena, Shubha Priyamvada, et al.
American Journal of Physiology. Cell Physiology
|
September 5, 2019
Decreased SLC26A3 expression and function in intestinal epithelial cells in response to <i>Cryptosporidium parvum</i> infection
Anoop Kumar, Dulari Jayawardena, Arivarasu N Anbazhagan, et al.
Page
of 3